Alp Invest Partners B.V. Syros Pharmaceuticals, Inc. Transaction History

Alp Invest Partners B.V.

  • $140 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
$5.21 - $11.03 $78,150 - $165,450
-15,000 Closed
0 $0
Q1 2020

May 13, 2020
BUY
$4.46 - $9.2 $66,900 - $138,000
15,000 New
15,000 $89,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $4.25M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Alp Invest Partners B.V. Portfolio

Follow Alp Invest Partners B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alp Invest Partners B.V., based on Form 13F filings with the SEC.

News

Stay updated on Alp Invest Partners B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email